GEXVal Featured in BioCentury Article
2025年12月22日
株式會社GEXValDecember 22, 2025 GEXVal Featured in BioCentury Article “Raising the Sun: Japan Biotech Looks to Lev […]
GEXVal Senior Director Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025年12月12日
株式會社GEXValDecember 12, 2025 GEXVal Senior Director Delivers Lecture at University of Tokyo Hospital TR/Academi […]
GEXVal CEO Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025年11月21日
株式會社GEXValNovember 21, 2025 GEXVal CEO Delivers a Lecture at University of Tokyo Hospital TR/Academia Drug Dis […]
GEXVal Receives FDA Orphan Drug Designation for GXV-001 in Fragile X Syndrome
2025年11月19日
株式會社GEXValNovember 19, 2025 GEXVal Receives FDA Orphan Drug Designation for GXV-001 in Fragile X Syndrome GEXV […]

